Ustekinumab Improves Health-Related Quality of Life in Patients with Moderate-to-severe Crohn's Disease: Results Up to Week 104 of the STARDUST Trial
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL(2023)
Key words
Crohn's disease,health-related quality of life,standard of care,tight monitoring,treat-to-target,ustekinumab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined